BTIG analyst Timothy Chiang downgraded Synergy Pharmaceuticals (NASDAQ: SGYP) from Buy to Neutral.The analyst comments "While we had been aware ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE